The global Systemic Aspergillosis and Systemic Candidasis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Systemic Aspergillosis and Systemic Candidasis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Aspergillosis and Systemic Candidasis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Systemic Aspergillosis and Systemic Candidasis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Systemic Aspergillosis and Systemic Candidasis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Other

Segment by Application
CPA
ABPA
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other